Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Chiesi, Arbor in US$ 2 bn gene therapy deal; Lilly to invest over US$ 1 bn in India; FDA okays Boehringer's rare lung disease drug

In news this week, Italy’s Chiesi Group announced a deal worth up to US$ 2 billion with US-based Arbor Biotechnologies to...

Impressions : 3066

Trump, Pfizer seal deal to offer drug discounts; FDA approves Eli Lilly's oral breast cancer pill

This week, US President Donald Trump announced a deal with Pfizer to sell medicines through a new federal website, TrumpRx.go...

Impressions : 585

Pfizer buys Metsera for up to US$ 7.3 bn, Roche acquires 89bio; FDA okays injectable version of Merck's Keytruda

In this week’s Phispers, Pfizer announced the acquisition of New York-based biotech Metsera for up to US$ 7.3 billion, ma...

Impressions : 1257

Novartis inks US$ 5.7 bn licensing deal with Monte Rosa for immune-related diseases; GSK, Lilly pledge more investments in US

In this week’s news, drugmakers continued to invest heavily in the US in order to avoid tariffs. GSK said it will invest ...

Impressions : 913

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Chiesi, Arbor in US$ 2 bn gene therapy deal; Lilly to invest over US$ 1 bn in India; FDA okays Boehringer's rare lung disease drug

Trump, Pfizer seal deal to offer drug discounts; FDA approves Eli Lilly's oral breast cancer pill

Pfizer buys Metsera for up to US$ 7.3 bn, Roche acquires 89bio; FDA okays injectable version of Merck's Keytruda

Novartis inks US$ 5.7 bn licensing deal with Monte Rosa for immune-related diseases; GSK, Lilly pledge more investments in US

Amneal Pharms's Generics Isotretinoin Receives Approval in US

SQ Innovation's Lasix Onyu Receives Approval In US

Boehringer Ingelheim's Jascayd Receives Approval In US

Taro's Generics Lamotrigine Receives Approval In US

Lotus's Generics Nintedanib Receives Tentative Approval In US

Annora's Generics Mirtazapine Receives Approval in US

Changzhou's Generics Doxycycline Receives Approval in US

Dr Reddys's Generics Prednisone Receives Approval in US

Annora's Generics Bupropion Hydrochloride Receives Approval in US

Eli Lilly's Inluriyo Receives Approval in US

Enforcement Report - Week of October 8, 2025

Prothya Biosolutions Netherlands B.V.'s Fails EDQM inspection

Health Canada Issues Recalls of Sandoz's Lisinopril tablet

FDA Issues Form 483 to Aurobindo Pharmaceuticals

Enforcement Report - Week of October 1, 2025.pdf

FDA Issues Form 483 to Dr. Reddy Lab

Persōn & Covey Recieves Warning Letter

Sichuan Savory Biotechnology is on FDA Import Alert List

Guangxi Yulin Pharmaceutical is on FDA Import Alert List

Produlab Pharma B.V's Fails EDQM inspection

Insulet to Host Investor Day on November 20, 2025

How Boehringer Ingelheim Is Buttressing Its US Business

Pelthos Rolls Out Campaign Aimed At Moms Who 'Don'T Mess Around'

Senate Backs China Competition Amendment In Defense Bill

Astrazeneca To Formalize MFN Agreement With Trump: MSNBC

Genflow Biosciences PLC Announces Update On Animal Health Program

Aytu Biopharma To Present At Upcoming October 2025 Conferences

Cognixion Recognized By TIME For Best Inventions Of 2025

ME Therapeutics Added To CSE25 Index

NTG Nordic Transport Group A/S - Q3 2025 Conference Call

Tariff Pause Eases Pressure On Drug Companies

Natco Wins Patent Battle To Launch Generic 'Risdiplam'

Trump & Co Halts Generic Drug Tariffs, Boosts Indian Pharma Stock

Zydus Gets Health Canada Approval For Liothyronine Tablets

Pharmanovia Appoints Stephan Eder As CEO

Biocon Unit Gets USFDA Nod For Genetic Anti-Bacterial Drug

Gilead Inks Biktarvy Settlements With 3 Generic Drug Makers

Supreme Court Rejects Purdue's Oxycontin Patent Appeal

Zydus Lifesciences Gets USFDA Nod For Deflazacort Oral Suspension

Kennedy Push For Autism Drug Gets A Boost From Pharma

Genflow Biosciences PLC Announces Update On Animal Health Program

ME Therapeutics Added To CSE25 Index

Inflammation Biotech Evommune Eyes IPO To Fund Dermatitis Trials

BMS Inks $1.5B Deal To Pull Orbital Into Its Sphere Of Influence

Cabaletta's CAR-T Wipes Out B Cells With No Preconditioning

Novo Ends All Cell Therapy R&D, Lets Go Of Staff

Novo Strikes Up To $5.2B Deal For Akero In Red-Hot MASH Space

Ono's BMS-Partnered IO Drug Passes Phase 2 Gastric Cancer Test

Regcell Scientific Founder Dr. Shimon Sakaguchi Wins Nobel Prize

kedrion Biopharma's Yimmugo Now Available in The U.S

AZ Breaks Ground On $4.5B API Production Facility In Virginia

Asahi Kasei Launches Sonanos Next-Gen Excipients

HRV Pharma Unveils Brand Mascots

Piramal Pharma Solutions Implements POD Method At Aurora API

Supriya's Ambernath Facility Secures WHO GMP certification

A. P. Rameswara Rao Appointed National President Of BDMAI

US Urged To Diversify Antibiotic Imports To Cut Shortages

AbbVie Breaks Ground on Chicago API Manufacturing Plant

AGC Pharma Chemicals to Attend the 54th Organic Process R&D Conf.

Evonik Introduces Maxipure Polysorbate 80 For Injectable Drugs

CDSCO To Inspect Cough Syrup Manufacturing Units

EMA Allows Relying On FDA GMP Inspections Abroad

CDSCO Urges States To Ensure Raw Material Testing

India Declares Three Cough Syrups Toxic After Child Deaths

KFF Poll: US Parties Divided On Trump's Tylenol-Autism Claim

Maharashtra FDA Orders Inspection Of Liquid Oral Formulations

Xspray Hits FDA Wall With New Manufacturing-Related Rejection

WHO Calls out Gap in India's Cough Syrup Testing After Deaths

FDA Alerts On Gujarat Companies For DEG-Contaminated Cough Syrup

TN DCA Orders Full-Scale Seizure Of Contaminated Coldrif Syrup

Cognixion Recognized By TIME For Best Inventions Of 2025

MIT Rejects Trump Deal Tying Research Money To Certain Demands

Integris Medtech Files DRHP With SEBI For IPO